1. Radko-Juettner, Sandi, Yue, Hong, Myers, Jacquelyn A, Fischer, Eric S, Roberts, Charles W M. 2024. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF. In Nature, 628, 442-449. doi:10.1038/s41586-024-07250-1. https://pubmed.ncbi.nlm.nih.gov/38538798/
2. Leng, Feng, Yu, Jiekai, Zhang, Chunxiao, Lu, Fei, Zhang, Hui. 2018. Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase. In Nature communications, 9, 1641. doi:10.1038/s41467-018-04019-9. https://pubmed.ncbi.nlm.nih.gov/29691401/
3. Mansachs, Sara Juul, Villumsen, Sofie Olund, Johannesen, Jesper, Kaur, Simranjeet, Pociot, Flemming. 2022. Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes. In Genes, 13, . doi:10.3390/genes13050869. https://pubmed.ncbi.nlm.nih.gov/35627254/
4. Oehl-Jaschkowitz, Barbara, Vanakker, Olivier M, De Paepe, Anne, McKee, Shane, Tzschach, Andreas. 2013. Deletions in 14q24.1q24.3 are associated with congenital heart defects, brachydactyly, and mild intellectual disability. In American journal of medical genetics. Part A, 164A, 620-6. doi:10.1002/ajmg.a.36321. https://pubmed.ncbi.nlm.nih.gov/24357125/